Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The superficial femoral artery is a major blood vessel in the thigh that continues from the common femoral artery distal to the origin of the deep femoral artery. It travels through the adductor canal and becomes the popliteal artery at the adductor hiatus. The SFA is unique among arteries due to its complex anatomy and hemodynamic characteristics, making it a common site of peripheral arterial disease and atherosclerotic complications. While the SFA itself is not a drug target, it is frequently accessed for endovascular interventions in treating coronary and peripheral vascular disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Superficial femoral artery (SFA).